Showing results (31-40 of 106) with videos related to
Sort By:
Pageof 11
Blood|June 9, 2012
MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterationsIléana Antony-Debré, Dominique Bluteau, Raphael Itzykson, et al.Cancer Genetics|September 6, 2021
Germline mutation in the NBR1 gene involved in autophagy detected in a family with renal tumorsFlorine Adolphe, Sophie Ferlicot, Virginie Verkarre, et al.Haematologica|May 4, 2019
Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemiaAllan Beke, Lucie Laplane, Julie Riviere, et al.Cell Death & Disease|May 26, 2017
DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residuesValérie Glorian, Jennifer Allègre, Jean Berthelet, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cellsCarl De Trez, Kirsten Schneider, Karen Potter, et al.Cell Death & Disease|July 18, 2018
Correction: DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residuesValérie Glorian, Jennifer Allègre, Jean Berthelet, et al.American Journal of Medical Genetics. Part A|December 7, 2013
Congenital neutropenia with retinopathy, a new phenotype without intellectual deficiency or obesity secondary to VPS13B mutationsLucie Gueneau, Laurence Duplomb, Pierre Sarda, et al.Iscience|January 15, 2025
Monocytes generated by interleukin-6-treated human hematopoietic stem and progenitor cells secrete calprotectin that inhibits erythropoiesisValentine Marchand, Lucie Laplane, Louis Valensi, et al.European Journal of Cancer (Oxford, England : 1990)|November 27, 2021
Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutationAnne Patsouris, Kadija Diop, Olivier Tredan, et al.Journal of Cellular and Molecular Medicine|December 21, 2016
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0Vladimir T Manchev, Hind Bouzid, Iléana Antony-Debré, et al.Pageof 11